VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Tuesday, December 30, 2025
Stock Comparison
PepsiCo, Inc. vs Sanofi
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
PepsiCo, Inc.
PEP · Nasdaq Global Select Market
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into PepsiCo, Inc.'s moat claims, evidence, and risks.
View PEP analysisSanofi
SAN · Euronext Paris
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Comparison highlights
- Moat score gap: Sanofi leads (74 / 100 vs 72 / 100 for PepsiCo, Inc.).
- Segment focus: PepsiCo, Inc. has 7 segments (27% in Frito-Lay North America (FLNA)); Sanofi has 3 segments (79.8% in Pharma (Prescription Medicines)).
- Moat breadth: PepsiCo, Inc. has 4 moat types across 2 domains; Sanofi has 5 across 3.
Primary market context
PepsiCo, Inc.
Frito-Lay North America (FLNA)
Branded convenient foods (salty snacks, dips and adjacent categories)
United States and Canada
Retailers, convenience stores, foodservice
Branded manufacturer + distributor (DSD/warehouse/distributor networks)
27%
Sanofi
Pharma (Prescription Medicines)
Branded prescription pharmaceuticals (immunology, rare disease, neurology, oncology, general medicines)
Global
Patients via payers/providers and channel partners (wholesalers, pharmacies, hospitals)
Research-based drug developer, manufacturer, and marketer
79.8%
Side-by-side metrics
Moat coverage
Shared moat types
PepsiCo, Inc. strengths
Sanofi strengths
Segment mix
PepsiCo, Inc. segments
Full profile >Frito-Lay North America (FLNA)
Oligopoly
Quaker Foods North America (QFNA)
Competitive
PepsiCo Beverages North America (PBNA)
Oligopoly
Latin America (LatAm)
Oligopoly
Europe
Oligopoly
Africa, Middle East and South Asia (AMESA)
Competitive
Asia Pacific, Australia & New Zealand and China Region (APAC)
Competitive
Sanofi segments
Full profile >Pharma (Prescription Medicines)
Oligopoly
Vaccines
Oligopoly
Opella (Consumer Healthcare - Sanofi minority stake)
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.